EFIENT

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom, South Africa

Active ingredients

The drug EFIENT contains one active pharmaceutical ingredient (API):

1 Prasugrel
UNII G89JQ59I13 - PRASUGREL HYDROCHLORIDE

Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke.

Read about Prasugrel

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
EFIENT Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B01AC22 Prasugrel B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 05386702, 05743527, 05871834, 05906484, 06562414, 06568693, 06568701, 07580526, 07668273, 07745186, 07745192, 09188844, 09188867, 09188896, 09188910, 09276198, 09276206, 09902365, 10535914, 11309634, 11861610, 12505840, 12505857, 12593198, 12652328, 12652340, 14266322, 14266339, 14355994, 16354668, 16768619, 17390123, 17541042
Country: EE Ravimiamet Identifier(s): 1412862, 1412941, 1412963, 1412974, 1412985, 1412996, 1413009, 1413010, 1413021, 1413032, 1413043, 1413054, 1413065, 1413076
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 08503002, 08503009, 08503013
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 034468, 034479
Country: FR Base de données publique des médicaments Identifier(s): 65916489
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 152403, 152412, 374349, 374414, 381317, 386063
Country: IE Health Products Regulatory Authority Identifier(s): 13741, 13809, 13856, 27007
Country: IT Agenzia del Farmaco Identifier(s): 039055025, 039055090
Country: JP 医薬品医療機器総合機構 Identifier(s): 3399009F1020, 3399009F2026, 3399009F3022, 3399009F5025
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1036507, 1036508, 1036509, 1036510, 1036511, 1036512, 1036513, 1036514, 1036515, 1036516, 1036517, 1036518, 1036519, 1036520, 1063748, 1063749
Country: NL Z-Index G-Standaard, PRK Identifier(s): 90530, 90549
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100206170, 100206187
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W62438001, W62438002, W62438003, W62438004, W62438005, W62438006, W62438007, W62439001, W62439002, W62439003, W62439004, W62439005, W62439006, W62439007
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 12073011, 12073012
Country: ZA Health Products Regulatory Authority Identifier(s): 43/8.2/0242, 43/8.2/0243

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.